IP Verse

Cafa Therapeutics Limited opposition analysis

COMPANY ANALYSIS

Patent:

Grant Date:

Dec 14, 2022

Title:

Compositions And Methods Of Cellular Immunotherapy

Oppositions:

Patent:

Grant Date:

Sep 4, 2019

Title:

Immunologic Effector Cell Of Targeted Cld18A2, And Preparation Method And Use Thereof

Oppositions:

Patent Number	Grant Date	Title	Total Oppositions
EP3445407	Dec 14, 2022	Compositions And Methods Of Cellular Immunotherapy	2
EP3170842	Sep 4, 2019	Immunologic Effector Cell Of Targeted Cld18A2, And Preparation Method And Use Thereof	1

BIONTECH CELL & GENE THERAPIES GMBH

MURGITROYD & COMPANY

SOTIO BIOTECH INC.

Feel free to send us a message here and we will get back to you